Framing and managing cardiovascular risk in chronic kidney disease: from native to transplanted kidney

E. Dounousi, A. Duni, S. Marinaki, J. N. Boletis
{"title":"Framing and managing cardiovascular risk in chronic kidney disease: from native to transplanted kidney","authors":"E. Dounousi,&nbsp;A. Duni,&nbsp;S. Marinaki,&nbsp;J. N. Boletis","doi":"10.1002/cce2.52","DOIUrl":null,"url":null,"abstract":"<div>\n \n \n <section>\n \n <p>Cardiovascular disease is the most common cause of death among chronic kidney disease (CKD) patients. As renal function declines, kidney-specific risk factors for cardiovascular events emerge. The aim of this review is to provide an insight on classical as well as non-traditional, kidney-related cardiovascular risk factors with regard to different stages of CKD, including ESRD and renal transplantation, and address specific strategies of cardiovascular disease prevention. Main culprits related to increased cardiovascular risk in patients with CKD include renin–angiotensin system and sympathetic overactivity, endothelial dysfunction, chronic inflammation, and oxidative stress. The CKD associated metabolic bone disorder (CKD-MBD), is associated with cardiovascular effects beyond the already established renal osteodystrophy and hyperparathyroidism. Higher circulating levels of phosphate and fibroblast growth factor 23 (FGF-23) and low vitamin D levels have been linked to increased risk of cardiovascular disease in patients with CDK. Uremia-related as well as renal replacement modality associated factors emerge in patients who initiate renal replacement therapy. Kidney transplant recipients (KTRs) have a lower risk of major cardiovascular events compared with dialysis patients, however conventional cardiovascular risk factors such as dyslipidemia, hypertension, and diabetes are amplified in KTRs, due to the use of immunosuppressive drugs which possess diabetogenic and atherogenic effects. Renal allograft dysfunction is a major risk factor for cardiovascular disease in this patient group. Prevention in the early stages of CKD and multifactorial aggressive interventions targeting established cardiovascular risk factors should be priority whereas future research and randomized clinical trials should assess new management approaches focusing on non-classical risk factors.</p>\n </section>\n \n <section>\n \n <p><b>Answer questions and earn CME:</b> https://wileyhealthlearning.com/Activity2/5430062/Activity.aspx</p>\n </section>\n </div>","PeriodicalId":100331,"journal":{"name":"Continuing Cardiology Education","volume":"3 2","pages":"70-77"},"PeriodicalIF":0.0000,"publicationDate":"2017-07-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1002/cce2.52","citationCount":"2","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Continuing Cardiology Education","FirstCategoryId":"1085","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1002/cce2.52","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 2

Abstract

Cardiovascular disease is the most common cause of death among chronic kidney disease (CKD) patients. As renal function declines, kidney-specific risk factors for cardiovascular events emerge. The aim of this review is to provide an insight on classical as well as non-traditional, kidney-related cardiovascular risk factors with regard to different stages of CKD, including ESRD and renal transplantation, and address specific strategies of cardiovascular disease prevention. Main culprits related to increased cardiovascular risk in patients with CKD include renin–angiotensin system and sympathetic overactivity, endothelial dysfunction, chronic inflammation, and oxidative stress. The CKD associated metabolic bone disorder (CKD-MBD), is associated with cardiovascular effects beyond the already established renal osteodystrophy and hyperparathyroidism. Higher circulating levels of phosphate and fibroblast growth factor 23 (FGF-23) and low vitamin D levels have been linked to increased risk of cardiovascular disease in patients with CDK. Uremia-related as well as renal replacement modality associated factors emerge in patients who initiate renal replacement therapy. Kidney transplant recipients (KTRs) have a lower risk of major cardiovascular events compared with dialysis patients, however conventional cardiovascular risk factors such as dyslipidemia, hypertension, and diabetes are amplified in KTRs, due to the use of immunosuppressive drugs which possess diabetogenic and atherogenic effects. Renal allograft dysfunction is a major risk factor for cardiovascular disease in this patient group. Prevention in the early stages of CKD and multifactorial aggressive interventions targeting established cardiovascular risk factors should be priority whereas future research and randomized clinical trials should assess new management approaches focusing on non-classical risk factors.

Answer questions and earn CME: https://wileyhealthlearning.com/Activity2/5430062/Activity.aspx

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
慢性肾脏疾病心血管风险的构建和管理:从原生肾到移植肾
心血管疾病是慢性肾脏疾病(CKD)患者最常见的死亡原因。随着肾功能下降,心血管事件的肾脏特异性危险因素出现。本综述的目的是提供关于不同阶段CKD(包括ESRD和肾移植)的经典和非传统肾脏相关心血管危险因素的见解,并提出心血管疾病预防的具体策略。与CKD患者心血管风险增加相关的罪魁祸首包括肾素-血管紧张素系统和交感神经过度活跃、内皮功能障碍、慢性炎症和氧化应激。CKD相关的代谢性骨疾病(CKD- mbd),除了已经建立的肾性骨营养不良和甲状旁腺功能亢进外,还与心血管影响相关。高循环水平的磷酸盐和成纤维细胞生长因子23 (FGF-23)和低维生素D水平与CDK患者心血管疾病的风险增加有关。尿毒症相关以及肾脏替代方式相关因素出现在开始肾脏替代治疗的患者中。与透析患者相比,肾移植受者(KTRs)发生主要心血管事件的风险较低,然而,由于使用具有致糖尿病和动脉粥样硬化作用的免疫抑制药物,KTRs中血脂异常、高血压和糖尿病等传统心血管危险因素被放大。同种异体肾移植功能障碍是该患者组心血管疾病的主要危险因素。CKD早期阶段的预防和针对心血管危险因素的多因素积极干预应该是优先考虑的,而未来的研究和随机临床试验应该评估新的管理方法,重点关注非经典危险因素。回答问题并获得CME: https://wileyhealthlearning.com/Activity2/5430062/Activity.aspx
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
自引率
0.00%
发文量
0
期刊最新文献
Issue Information Myocardial perfusion SPECT and SPECT/CT in interventional cardiology Abdominal aortic aneurysm: screening and management Pulmonary arterial hypertension in congenital heart disease Current knowledge on very late stent thrombosis
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1